Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2010; 6(1): 197-203


THE THERAPEUTIC EFFECT OF ANTOX AND SINGULAR AGAINST PARAQUAT LUNG TOXICITY IN MALE ALBINO RATS

Faten R. Abdel Ghaffar Ibrahem A. El-Elaimy Saber A. Sakr Fathy A. Bayumy.




Abstract

The ameliorative effect of Antox and Singular drugs, separately or in combination, against paraquat, herbicide-induced lung toxicity were studied in albino rat (120 ± 10 g BW). Paraquat was injected as a single dose of 1/20 LD50 (2.5 mg /kg BW, i.p.). Whereas antox (0.27 ml/ 100 g BW, orally), singular (0.23 ml/100 g BW, orally) and Antox + Singular were introduced for the rats (once a day for 4 weeks) 48 hours - after paraquat injection. Blood catalase, serum superoxide dismutase and c- reactive protein, as well as interleukin- 6 recorded highly significant elevation due to paraquat lung intoxication. During intervals (1, 2, and 4 weeks) of drugs treatment, the therapeutic effect of Antox or Singular, separately, was limited compared to that of their combination. However, the longer the time after (Antox + Singular) treatment the more is the amelioration for the studied biomarkers. The mechanisms of paraquat induced lung intoxication and the therapeutic effect of Antox and Singular drugs were discussed.

Key words: Paraquat, Rats, Lung, Toxicity, Antox, Singular






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.